文献速递前列腺癌

冰冻切片对机器人辅助腹腔镜前列腺切除术长期结局的影响

Impact of frozen section on long-term outcomes in robot-assisted laparoscopic prostatectomy.
PubMed 文献 · BJU Int · 2024-07-03

本研究基于前瞻性数据库,比较行机器人辅助腹腔镜前列腺切除术(RALP)时采用神经血管结构旁冰冻切片检查(NeuroSAFE)与未采用(标准治疗)患者的1年功能与5年肿瘤学结局。结果显示两组5年生化复发率与1年尿失禁风险相当,但NeuroSAFE组1年勃起功能障碍风险显著降低。

要点

  • 两组5年生化复发率相似(11% vs 11%,P=0.9),多因素分析HR 1.2(P=0.6)。
  • 1年尿失禁风险两组相当(OR 0.59,95%CI 0.17-1.6;P=0.4)。
  • NeuroSAFE组1年勃起功能障碍风险显著降低(OR 0.37,95%CI 0.22-0.60;P<0.001)。

核心结论

  • 对于行RALP的男性,与标准治疗相比,NeuroSAFE患者生化复发时间与1年尿失禁风险相当,1年勃起功能障碍风险显著降低。

研究设计与样本

  • 研究纳入2009年1月1日至2018年6月30日在本中心行RALP的男性,来自前瞻性维护数据库。
  • 排除术前治疗、术后辅助治疗或参加临床试验者,按是否使用NeuroSAFE分组,随访截尾于5年。
  • 共1199例连续男性行RALP,1140例符合条件,其中NeuroSAFE组317例,标准治疗组823例。

主要发现

  • 两组中位PSA随访均为60个月。
  • Kaplan-Meier分析5年生化复发率相似(11% vs 11%;P=0.9),多因素Cox模型生化复发时间风险比1.2(P=0.6)。
  • 1年时,与标准治疗组相比,NeuroSAFE组未调整尿失禁率5.1% vs 7.7%,未调整勃起功能障碍率57% vs 80%。
  • 多因素分析中,NeuroSAFE组尿失禁风险相当(OR 0.59,95%CI 0.17-1.6;P=0.4),勃起功能障碍风险显著降低(OR 0.37,95%CI 0.22-0.60;P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare 1-year functional and 5-year oncological outcomes of men undergoing robot-assisted laparoscopic prostatectomy (RALP) with neurovascular structure-adjacent frozen-section examination (NeuroSAFE) with those in men undergoing RALP without NeuroSAFE (standard of care [SOC]). SUBJECTS AND METHODS: Men undergoing RALP in our centre between 1 January 2009 and 30 June 2018 were enrolled from a prospectively maintained database. Patients were excluded if they had undergone preoperative therapy or postoperative adjuvant therapy or were enrolled in clinical trials. Patients were grouped based on use of NeuroSAFE. Follow-up was censored at 5 years. The primary outcome was difference in time to biochemical recurrence (BCR) on multivariable analysis, defined as prostate-specific antigen (PSA) >0.2 ng/L on two consecutive measurements. Secondary outcomes were difference in 1-year erectile dysfunction and incontinence. RESULTS: In the enrolment period, 1199 consecutive men underwent RALP, of whom 1140 were eligible, including 317 with NeuroSAFE and 823 with SOC. The median PSA follow-up was 60 months in both groups. Rates of 5-year BCR were similar on Kaplan-Meier survival curve analysis (11% vs 11%; P = 0.9), as was time to BCR on multivariable Cox proportional hazards modelling (hazard ratio 1.2; P = 0.6). Compared with the SOC group at 1 year, the NeuroSAFE group had similar unadjusted rates of incontinence (5.1% vs 7.7%) and lower unadjusted impotence (57% vs 80%). On multivariable analysis, NeuroSAFE patients had equivalent risk of incontinence (odds ratio [OR] 0.59, 95% CI 0.17-1.6; P = 0.4) but significantly reduced risk of erectile dysfunction (OR 0.37, 95% CI 0.22-0.60; P < 0.001). CONCLUSIONS: For men undergoing RALP, compared with SOC, NeuroSAFE patients had equivalent time to BCR and risk of 1-year incontinence, and significantly lower risk of 1-year erectile dysfunction.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Kinnear N, Fonseca PC, Ogbechie C, et al. Impact of frozen section on long-term outcomes in robot-assisted laparoscopic prostatectomy. BJU Int. 2024. PMID: 38961710. doi:10.1111/bju.16437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。